Otsuka Pharmaceutical Co., Ltd.’s $250 Million Acquisition of Neurovance, Inc

Overview


William Díaz led the multi-office team of William Hutchens, Byron Kalogerou, Sarah Kitchell, Andrew Liazos, Veleka Peeples-Dyer, Alejandro Ruiz, Albert Sokol, Kristian Werling and Daniel Zucker, which advised Neurovance, Inc. on its acquisition by major Japanese pharmaceutical company Otsuka Pharmaceutical.